FDA Inspection 706469 — Edlaw Pharmaceutical, Inc.

Edlaw Pharmaceutical, Inc. — FEI 2431908

The FDA completed an inspection of Edlaw Pharmaceutical, Inc. on January 10, 2011 in Farmingdale, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 10, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Farmingdale, NY (United States)

Citations

IDCFRDescription
323621 CFR 820.72(b)Calibration procedures - content
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations